Pfizer Urges JPML To Combine Zoloft Cases In NY

Law360, San Diego (March 29, 2012, 9:55 PM EDT) -- Nearly 100 pending actions accusing Pfizer Inc. of failing to adequately warn pregnant women that antidepressant Zoloft could cause birth defects should be centralized in the Southern District of New York, the New York-based drugmaker told a federal panel Thursday.

Pfizer's attorney Mark Cheffo of Skadden Arps Slate Meagher & Flom LLP said at a hearing before the U.S. Judicial Panel on Multidistrict Litigation that there are 95 actions across 16 federal courts bringing similar claims over Zoloft, up from 59 actions in seven district courts...
To view the full article, register now.